ACE2 and Parkinson disease: Another interaction mechanism involves the angiotensin‐converting enzyme 2 receptor (ACE2), which mediates viral entry and is implicated in Parkinson's disease pathophysiology—renin–angiotensin system dysregulation, neuroinflammation, oxidative stress, and dopaminergic degeneration.